Healthcare -
Biotechnology - NASDAQ - US
$ 40.74
4.25 %
$ 7.57 B
Market Cap
-11.38
P/E
Price Target
Average
43.31%
Revenue Forecast
Estimate
256.80%
EBIT
Estimate
--2.59%
Net Income
Estimate
20.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Revolution Medicines, Inc.
Wall Street analysts predict an average 1-year price target for RVMD of $58.4 , with forecasts ranging from
a
low of
$43 to a high of $82 .
RVMD Lowest Price Target
Wall Street Target
43 USD
5.55%
RVMD Average Price Target
Wall Street Target
58.4 USD
43.31%
RVMD Highest Price Target
Wall Street Target
82 USD
101.28%
REVENUE FORECAST
Revenue Forecast Chart RVMD
EBIT FORECAST
EBIT Forecast Chart RVMD
NET INCOME FORECAST
Net Income Chart RVMD